| NCT Number | NCT07732400 |
| Lead Sponsor | Kriya Therapeutics, Inc. |
| Conditions | Metabolic Dysfunction-associated Steatohepatitis (MASH) |
| Enrollment | 56 participants |
| Start Date | 2026-07 |
| Primary Completion | 2028-07 (estimated) |
| Study Completion | 2029-07 (estimated) |
| Updated on ClinicalTrials.gov | 2026-07-28 |